← Back to Search

Smartphone App for Post-Surgery Care in Bladder Cancer

N/A
Recruiting
Led By Jeffery Montgomery, M.D.
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing a radical cystectomy with reconstruction through GU Oncology Clinic
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 42 days post hospital discharge
Awards & highlights

Study Summary

This trial uses a smartphone app to help prevent readmissions after major cancer surgery, improving outcomes, reducing mortality, and saving costs.

Who is the study for?
This trial is for English-speaking bladder cancer patients at the University of Michigan who are undergoing radical cystectomy. Participants must have access to a smartphone or tablet with internet to use the CLEAR Care Companion app.Check my eligibility
What is being tested?
The study tests if a smartphone application, which tracks symptoms and provides educational content after major cancer surgery, can improve communication with doctors, patient satisfaction, and reduce hospital readmissions.See study design
What are the potential side effects?
Since this trial involves using an application rather than medication, traditional side effects are not expected. However, users may experience stress or frustration if technical issues arise while using the app.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am having bladder removal surgery with reconstruction.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~42 days post hospital discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 42 days post hospital discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Duration of engagement with application
Frequency of engagement with application
Patient Experience Survey -- Overall Care (all participants)
+2 more
Secondary outcome measures
Patient Experience Survey -- Application (all participants)
Patient Experience Survey -- Application (first 20 participants)
Readmission rate

Trial Design

1Treatment groups
Experimental Treatment
Group I: CLEAR CCExperimental Treatment1 Intervention
Patients use CLEAR CC application with Smartphone or Tablet

Find a Location

Who is running the clinical trial?

University of Michigan Rogel Cancer CenterLead Sponsor
293 Previous Clinical Trials
23,847 Total Patients Enrolled
Jeffery Montgomery, M.D.Principal InvestigatorUniversity of Michigan Rogel Cancer Center

Media Library

CLEAR CC Clinical Trial Eligibility Overview. Trial Name: NCT05578898 — N/A
Bladder Cancer Research Study Groups: CLEAR CC
Bladder Cancer Clinical Trial 2023: CLEAR CC Highlights & Side Effects. Trial Name: NCT05578898 — N/A
CLEAR CC 2023 Treatment Timeline for Medical Study. Trial Name: NCT05578898 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for newly enrolled participants to join this trial?

"Indeed, clinicaltrials.gov indicates that this medical experiment has been opened and is now recruiting participants since December 1st 2022. The last update to the study was November 8th 2022, with an aim of enrolling 250 patients at a single location."

Answered by AI

To what extent is this trial populated with participants?

"Affirmative. Clinicaltrials.gov confirms that this clinical trial, which was first made public on December 1st 2022, is currently recruiting participants for the study. 250 participants are required to join from a single medical centre."

Answered by AI
~144 spots leftby Aug 2026